
In eye care, AI has moved beyond pilots and promises and is settling into something more durable: the foundation of modern clinical workflows.
From the beginning, AI in Eye Care was built with a specific purpose: to serve as a bridge across the three O’s of eye care—ophthalmology, optometry and optical—and to create a shared space for information exchange across disciplines that too often learn in parallel rather than together. We believe AI will be transformative precisely because it accelerates learning across boundaries, and progress will depend on how effectively those boundaries come down.
That philosophy extends to how we publish. Much like the technology we cover, AI in Eye Care is intentionally multi-modal. We produce written analyses, a weekly podcast—Real Talk—that allows for candid, unscripted conversations and a video-based AI Innovator Series that puts faces and context behind the ideas. Each format captures something different, and together they reflect how modern clinicians actually learn.
Over the past year, that exchange has accelerated. The conversation around artificial intelligence in ophthalmology has matured from speculative curiosity to something far more grounded: clinical utility. We are no longer asking whether AI belongs in eye care. We are asking where it is already working—and where it still needs to earn its place.
What follows is not a forecast. It is a snapshot of where AI’s reach is being felt today, drawn from the themes that have surfaced consistently across our coverage.
The Surgical Renaissance: From Intuition to Data-Augmented Excellence
The most visceral shift in our specialty is happening in the operating room.
Ophthalmic surgery has always relied on experience and judgment—what we often call “surgical intuition.” That intuition remains central, but it is increasingly being augmented by real-time data and longitudinal learning that extend beyond any individual surgeon’s experience.
In one of our most discussed AI Innovator Series conversations, Dr. Uday Devgan explored what’s coming with the Horizon Surgical System. His framing was instructive: these platforms are not about autonomy; they are about context. Intraoperative guidance, tissue recognition and procedural awareness informed continuously by data—while the surgeon remains firmly in control.
We are seeing the same evolution in refractive surgery. As Devgan and others have noted, IOL power calculations are no longer static formulas frozen in time. They are becoming adaptive models, learning from postoperative outcomes at scale and refining predictions with every case. The result is not a loss of surgical artistry, but tighter refractive accuracy and greater consistency—data reinforcing judgment rather than replacing it.
This is the surgical renaissance AI enables: not automation for its own sake, but data-augmented excellence.
Redefining the Patient Journey: Virtual, Predictive and Friction-Light
AI’s influence is just as evident outside the OR, particularly in how patients enter and move through care.
Much of the historical friction in eye care has come from intake, triage and data-gathering processes that consume time without adding insight. Increasingly, AI systems are shifting that burden upstream, organizing information before the clinician ever enters the room.
As we explored in our coverage of the virtual exam room, this is not simply tele-ophthalmology rebranded. It is a model where diagnostic data, imaging and patient-reported inputs are integrated early, allowing clinicians to engage immediately at a higher level. In practice, this often restores the doctor-patient relationship by removing layers of clerical drag.
AI is also reshaping care through prediction. In her piece on personalizing treatment pathways, Catherine Bornbaum, PhD, MBA, described how subtle retinal biomarkers—often invisible even to trained specialists—can forecast disease progression in conditions like AMD and diabetic retinopathy.
This shift from reactive to anticipatory care reframes ophthalmology as longitudinal management rather than episodic intervention.
The Great Equalizer: AI and Global Health Equity
If there is a place where AI’s reach carries real moral weight, it is in access.
Dr. Hunter Cherwek, an AAO Outstanding Humantarian Awardee, has emphasized AI’s role as a tool for health equity. Autonomous and semi-autonomous screening systems are now being deployed in rural and resource-limited settings, providing reliable triage and subspecialist-level diagnostic support where ophthalmologists are scarce.
This is not about replacing physicians. It is about extending expertise. When used thoughtfully, AI becomes a force multiplier—bringing earlier detection and more consistent care to populations that have historically been underserved.
The Administrative Renaissance—and the Myth of Displacement
Some of AI’s most consequential effects remain largely invisible to patients, but are deeply felt by practices.
As Masoud Nafey, OD, MBA, FAAO, outlined in How AI Can Recapture Patients and Boost Optical Revenue, intelligent automation is reshaping recall, scheduling, patient retention and revenue cycle management. AI systems that identify patients who have fallen out of care or flag overdue interventions are becoming foundational to sustainable practice operations.
This reality has punctured one of the most persistent fears we addressed in 3 AI Myths Eye Care Should Leave Behind in 2026: displacement. The lived experience of the past year has been clear. AI has not replaced ophthalmologists. It has replaced clerical inefficiency.
As Dr. Nafey noted, today’s health care consumer increasingly expects a technology-forward experience. For many patients, an AI-enabled practice signals quality and organization—not the absence of human care.
Looking Ahead: From Novelty to Normalization
If there is one conclusion worth carrying into 2026, it is this: implementation is now the work.
The era of the demo is over. What remains is the harder task of integration—embedding AI into real workflows, aligning it with clinical incentives, and holding it to the same standards we apply to any medical tool.
At AI in Eye Care, our commitment remains unchanged: to serve as a bridge across ophthalmology, optometry and optical, and to facilitate the exchange of ideas that makes progress possible. AI’s reach is being felt today not because the technology is inevitable, but because clinicians, operators and innovators have chosen to make it usable.
The future of eye care will not be defined by algorithms alone—but by how thoughtfully we choose to deploy them. We hope you’ll continue the conversation with us at AI in Eye Care as this next chapter of eye care takes shape.

